PhD Position in UBE2N Targeting and Antitumor Immunity in Ovarian Cancer Centre François Baclesse in France

PhD opening in Cancer Biology at Inserm U1086 ANTICIPE , François Baclesse Comprehensive Cancer Center, in collaboration with Université de Caen Normandie , France. The project is titled “Targeting UBE2N and antitumor immunity for improved ovarian cancer treatment” and sits within the BioTICLA precision medicine in ovarian cancer axis, with access to the ORGAPRED tumor organoid core facility . Research tasks include characterizing UBE2N-targeting compounds and their effects in ovarian cancer mod...

We’re hiring a postdoctoral researcher for the RESTOR project, an innovative 3-year translational cancer research position funded by the French National Cancer Institute (INCa) . The project aims to develop a new therapeutic strategy to restore tumor sensitivity to DNA-damaging treatments through UBE2N inhibition . The successful candidate will investigate the mechanisms underlying treatment resistance and evaluate this approach using patient-derived tumor models . Research will focus on ovarian...

PhD opportunity in cancer biology at Université de Caen Normandie and Inserm U1086 ANTICIPE, hosted at the François Baclesse Comprehensive Cancer Center in Caen, France. The project focuses on the therapeutic potential of targeting UBE2N and its interplay with antitumor immunity in ovarian cancer . The research is designed to identify new therapeutic strategies by combining cancer and molecular biology, pharmacology, immuno-oncology, and patient-derived tumor organoid (PDTO) models. The successf...

The Institute of Pharmacology and Structural Biology (IPBS), affiliated with CNRS and the University of Toulouse, is offering a PhD opportunity within the BEST Doctoral Programme. This project, titled MAP-GET: Mapping of cellular targets following gene electrotransfer in tumors , is focused on biological sciences and cancer-related research. The work is situated at IPBS in Toulouse, a major research environment known for expertise in cancer biology, immunology, microbiology, structural biology, ...

Master 2 internship opportunity in the Pharmacy department of UFR3S at the University of Lille , France. The project focuses on accelerated virtual screening of the GPR35 receptor for inflammatory bowel disease , with an emphasis on identifying new selective GPR35 agonists, ideally biased toward the anti-inflammatory β-arrestin-2 pathway. The intern will work with Corentin Bedart in the In silico Lille research group (Inserm Unit U1286 INFINITE). Planned work includes: developing a complete deep...